1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-injury frailty and clinical care trajectory of older adults with trauma injuries: A retrospective cohort analysis of a large level I US trauma center
    Journal Article

    Adeyemi, O.; Grudzen, C.; Dimaggio, C.; Wittman, I.; Velez-Rosborough, A.; Arcila-Mesa, M.; Cuthel, A.; Poracky, H.; Meyman, P.; Chodosh, J.
    PLoS ONE (2025)

    Fulltext@MSK | Save
  • Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer
    Journal Article

    Skoulidis, F.; Li, B. T.; Hochmair, M.; Govindan, R.; Vincent, M.; van der Wekken, A. J.; Aransay, N. R.; O’Byrne, K. J.; Girard, N.; Griesinger, F.; more...
    The Oncologist (2025)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary
    Journal Article

    Finch, L.; Andres, S.; Iasonos, A.; Zhou, Q.; Girshman, J.; Chhetri-Long, R.; Green, H.; Selenica, P.; Jang, D.; O'Cearbhaill, R. E.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
    Journal Article

    Bhutani, M.; Robinson, M.; Foureau, D.; Atrash, S.; Paul, B.; Guo, F.; Grayson, J. M.; Ivanina-Foureau, A.; Pineda-Roman, M.; Varga, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study
    Journal Article

    André, T.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Microwave ablation of refractory oligometastatic non–small cell lung cancer in the liver
    Journal Article

    Geevarghese, R.; Kunin, H.; Petre, E. N.; Deng, R.; Jain, S.; Sotirchos, V. S.; Zhao, K.; Sofocleous, C. T.; Solomon, S. B.; Ziv, E.; more...
    Journal of Vascular and Interventional Radiology (2025)

    Fulltext@MSK | Save
  • Consolidation ALK tyrosine kinase inhibitors versus durvalumab or observation after chemoradiation in unresectable stage III ALK-positive NSCLC
    Journal Article

    Nassar, A. H.; Jayakrishnan, R.; Feng, J.; Shepherd, F.; Adib, E.; Cheung, J. M.; Lin, J. J.; Liu, Y.; Lin, S. H.; Parikh, K.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Journal Article

    Lau, G.; Abou-Alfa, G. K.; Cheng, A. L.; Sukeepaisarnjaroen, W.; Van Dao, T.; Kang, Y. K.; Thungappa, S. C.; Kudo, M.; Sangro, B.; Kelley, R. K.; more...
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Adjuvant nivolumab for localized renal cell carcinoma at high risk of recurrence after nephrectomy: Part b of the randomized, placebo-controlled, phase III CheckMate 914 Trial
    Journal Article

    Motzer, R. J.; Bex, A.; Russo, P.; Tomita, Y.; Cutuli, H. J.; Rojas, C.; Gross-Goupil, M.; Schinzari, G.; Melichar, B.; Barthélémy, P.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save